TY - JOUR AU - Heeley E. AU - Sturm J. AU - Krishnamurthi R. AU - Correia M. AU - Thrift A. AU - Appelros P. AU - Rothwell P. AU - Anderson Craig AU - Feigin V. AU - Barker-Collo S. AU - Phan H. AU - Blizzard C. AU - Reeves M. AU - Cadilhac D. AU - Otahal P. AU - Konstantinos V. AU - Parmar P. AU - Bejot Y. AU - Cabral N. AU - Carolei A. AU - Sacco S. AU - Chausson N. AU - Olindo S. AU - Silva C. AU - Magalhaes R. AU - Korv J. AU - Vibo R. AU - Minelli C. AU - Gall S. AB -

BACKGROUND: Women are reported to have greater mortality after stroke than men, but the reasons are uncertain. We examined sex differences in mortality at 1 and 5 years after stroke and identified factors contributing to these differences. METHODS AND RESULTS: Individual participant data for incident strokes were obtained from 13 population-based incidence studies conducted in Europe, Australasia, South America, and the Caribbean between 1987 and 2013. Data on sociodemographics, stroke-related factors, prestroke health, and 1- and 5-year survival were obtained. Poisson modeling was used to estimate the mortality rate ratio (MRR) for women compared with men at 1 year (13 studies) and 5 years (8 studies) after stroke. Study-specific adjusted MRRs were pooled to create a summary estimate using random-effects meta-analysis. Overall, 16 957 participants with first-ever stroke followed up at 1 year and 13 216 followed up to 5 years were included. Crude pooled mortality was greater for women than men at 1 year (MRR 1.35; 95% confidence interval, 1.24-1.47) and 5 years (MRR 1.24; 95% confidence interval, 1.12-1.38). However, these pooled sex differences were reversed after adjustment for confounding factors (1 year MRR, 0.81; 95% confidence interval, 0.72-0.92 and 5-year MRR, 0.76; 95% confidence interval, 0.65-0.89). Confounding factors included age, prestroke functional limitations, stroke severity, and history of atrial fibrillation. CONCLUSIONS: Greater mortality in women is mostly because of age but also stroke severity, atrial fibrillation, and prestroke functional limitations. Lower survival after stroke among the elderly is inevitable, but there may be opportunities for intervention, including better access to evidence-based care for cardiovascular and general health.

AD - From the Menzies Institute for Medical Research Tasmania, University of Tasmania, Hobart, Australia (H.T.P., C.L.B., P.O., S.G.); Department of Health Management and Health Economics, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam (H.T.P.); Department of Epidemiology and Biostatistics, Michigan State University, East Lansing (M.J.R.); Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia (A.G.T., D.C.); Florey Institute Neuroscience and Mental Health, Heidelberg, University of Melbourne, Victoria, Australia (D.C.); Faculty of Health and Medicine, University of Newcastle, New South Wales, Australia (J.S.); George Institute for Global Health, University of Sydney, New South Wales, Australia (E.H., C.A.); Hellenic Cardiovascular Research Society, Athens, Greece (V.K.); National Institute for Stroke and Applied Neurosciences, School of Public Health and Psychosocial Studies, Auckland, New Zealand (P.P., R.K., V.F.); School of Psychology, University of Auckland, New Zealand (S.B.-C.); University of Burgundy, Dijon, France (Y.B.); University Hospital of Dijon, France (Y.B.); Clinica Neurologica de Joinville, Joinville Stroke Registry, University of Joinville Region-Univille, Brazil (N.L.C.); Department of Biotechnological and Applied Clinical Sciences, Neurological Institute, University of L'Aquila, Italy (A.C., S.S.); Stroke Unit, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France (N.C.); Stroke Unit, University Hospital of Bordeaux, France (S.O.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom (P.R.); UNIFAI, Instituto de Ciencias Biomedicas de Abel Salazar, Universidade do Porto, Portugal (C.S., M.C., R.M.); Department of Neurology, Faculty of Medicine and Health, Orebro University, Sweden (P.A.); Department of Neurology and Neurosurgery, University of Tartu, Estonia (J.K., R.V.); and Departamento de Neurologia, Psicologia e Psiquiatria, Universidade de Sao Paulo, Ribeirao Preto, Brazil (C.M.).
From the Menzies Institute for Medical Research Tasmania, University of Tasmania, Hobart, Australia (H.T.P., C.L.B., P.O., S.G.); Department of Health Management and Health Economics, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam (H.T.P.); Department of Epidemiology and Biostatistics, Michigan State University, East Lansing (M.J.R.); Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia (A.G.T., D.C.); Florey Institute Neuroscience and Mental Health, Heidelberg, University of Melbourne, Victoria, Australia (D.C.); Faculty of Health and Medicine, University of Newcastle, New South Wales, Australia (J.S.); George Institute for Global Health, University of Sydney, New South Wales, Australia (E.H., C.A.); Hellenic Cardiovascular Research Society, Athens, Greece (V.K.); National Institute for Stroke and Applied Neurosciences, School of Public Health and Psychosocial Studies, Auckland, New Zealand (P.P., R.K., V.F.); School of Psychology, University of Auckland, New Zealand (S.B.-C.); University of Burgundy, Dijon, France (Y.B.); University Hospital of Dijon, France (Y.B.); Clinica Neurologica de Joinville, Joinville Stroke Registry, University of Joinville Region-Univille, Brazil (N.L.C.); Department of Biotechnological and Applied Clinical Sciences, Neurological Institute, University of L'Aquila, Italy (A.C., S.S.); Stroke Unit, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France (N.C.); Stroke Unit, University Hospital of Bordeaux, France (S.O.); Stroke Prevention Research Unit, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom (P.R.); UNIFAI, Instituto de Ciencias Biomedicas de Abel Salazar, Universidade do Porto, Portugal (C.S., M.C., R.M.); Department of Neurology, Faculty of Medicine and Health, Orebro University, Sweden (P.A.); Department of Neurology and Neurosurgery, University of Tartu, Estonia (J.K., R.V.); and Departamento de Neurologia, Psicologia e Psiquiatria, Universidade de Sao Paulo, Ribeirao Preto, Brazil (C.M.). seana.gall@utas.edu.au. AN - 28228454 BT - Circ Cardiovasc Qual OutcomesCirc Cardiovasc Qual OutcomesCirculation: Cardiovascular Quality and Outcomes DP - NLM ET - 2017/02/24 J2 - Circulation. Cardiovascular quality and outcomes LA - eng LB - AUS
NMH
OCS
FY17 M1 - 2 N1 - Phan, Hoang T
Blizzard, Christopher L
Reeves, Mathew J
Thrift, Amanda G
Cadilhac, Dominique
Sturm, Jonathan
Heeley, Emma
Otahal, Petr
Konstantinos, Vemmos
Anderson, Craig
Parmar, Priya
Krishnamurthi, Rita
Barker-Collo, Suzanne
Feigin, Valery
Bejot, Yannick
Cabral, Norberto L
Carolei, Antonio
Sacco, Simona
Chausson, Nicolas
Olindo, Stephane
Rothwell, Peter
Silva, Carolina
Correia, Manuel
Magalhaes, Rui
Appelros, Peter
Korv, Janika
Vibo, Riina
Minelli, Cesar
Gall, Seana
United States
Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e003436. doi: 10.1161/CIRCOUTCOMES.116.003436. Epub 2017 Feb 22. N2 -

BACKGROUND: Women are reported to have greater mortality after stroke than men, but the reasons are uncertain. We examined sex differences in mortality at 1 and 5 years after stroke and identified factors contributing to these differences. METHODS AND RESULTS: Individual participant data for incident strokes were obtained from 13 population-based incidence studies conducted in Europe, Australasia, South America, and the Caribbean between 1987 and 2013. Data on sociodemographics, stroke-related factors, prestroke health, and 1- and 5-year survival were obtained. Poisson modeling was used to estimate the mortality rate ratio (MRR) for women compared with men at 1 year (13 studies) and 5 years (8 studies) after stroke. Study-specific adjusted MRRs were pooled to create a summary estimate using random-effects meta-analysis. Overall, 16 957 participants with first-ever stroke followed up at 1 year and 13 216 followed up to 5 years were included. Crude pooled mortality was greater for women than men at 1 year (MRR 1.35; 95% confidence interval, 1.24-1.47) and 5 years (MRR 1.24; 95% confidence interval, 1.12-1.38). However, these pooled sex differences were reversed after adjustment for confounding factors (1 year MRR, 0.81; 95% confidence interval, 0.72-0.92 and 5-year MRR, 0.76; 95% confidence interval, 0.65-0.89). Confounding factors included age, prestroke functional limitations, stroke severity, and history of atrial fibrillation. CONCLUSIONS: Greater mortality in women is mostly because of age but also stroke severity, atrial fibrillation, and prestroke functional limitations. Lower survival after stroke among the elderly is inevitable, but there may be opportunities for intervention, including better access to evidence-based care for cardiovascular and general health.

PY - 2017 SN - 1941-7705 (Electronic)
1941-7713 (Linking) ST - Circulation. Cardiovascular quality and outcomes T2 - Circ Cardiovasc Qual OutcomesCirc Cardiovasc Qual OutcomesCirculation: Cardiovascular Quality and Outcomes TI - Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy): A Meta-Analysis of Individual Participant Data VL - 10 Y2 - FY17 ER -